REFERENCES
- Tyrer P. Dependence as a limiting factor in the clinical use of minor tranquilizers. Pharmacol Ther 1988; 36: 173–88.
- Garrety DJ, Wolff K, Hay AW, Raistrick D. Benzodiazepines in drug addicts. Ann Clin Biochem 1997; 34: 68–73.
- Bertz RJ, Granneman GR. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 1997; 32: 210–58.
- Kaplan SA, Jack ML, Alexander K, Weinfeld RE. Pharmacokinetic profile of diazepam in man fol-lowing single intravenous and oral and chronic oral administrations. J Pharmaceut Sci 1973; 62: 1789–96.
- Greenblatt DJ, Shader RI, Divoll M, Harmatz JS. Benzodiazepines: a summary of pharmacokinetic properties. Br J Clin Pharmacol 1981; 11: 11S–6S.
- Beck 0, Lafolie P, Odelius G, Boreus L. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake. Toxicol Lett 1990; 52: 7–14.
- Meatherall R. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required. J Anal Toxicol 1994; 18: 385–90.
- Smith-Kielland A, Skuterud B, Morland J. Urinary excretion of amphetamine after termination of drug abuse. J Anal Toxicol 1997; 21: 325–9.
- Smith-Kielland A, Skuterud B, Morland J. Urinary excretion of 11-nor-9-carboxy-A9-tetrahydrocanna-binol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol 1999; 23: 323–32.
- Gjerde H, Dahlin E, Christophersen A. Simultaneous determination of common benzo-diazepin es in blood using capillary gas chromatog-raphy. J Pharm Biomed Anal 1992; 10: 317–22.
- Violon C, Vercruysse A. Screening procedure for therapeutic b enzodiazepin es by high-performance liquid chromatography of their benzophenones. J Chromatogr 1980; 189: 94–7.
- West RE, Ritz DP. GC/MS analysis of five common benzodiazepine metabolites in urine as tert-butyl-dimethylsilyl derivatives. J Anal Toxicol 1993; 17: 114–6.
- Bertilsson L. Geographical/interracial differ-ences in polymorphic drug oxidation. Clin Pharmacokinet 1995; 29: 192–209.